PDCD1 and neoplasm: Despite the increasing information on PD-1, a better understanding of the mechanisms regulating its expression and signaling in NK and helper ILC cells in the tumor context is required in order to further improve the current therapeutic approaches aimed to unleash PD-1-dependent immune cell blockade [46].